Xtant Medical GAAP EPS of $0.01 beats by $0.02, revenue of $33.26M beats by $0.56M

2025-11-10 17:15:47 ET

• Xtant Medical press release ( XTNT ): Q3 GAAP EPS of $0.01 beats by $0.02 .
• Revenue of $33.26M (+19.0% Y/Y) beats by $0.56M .
• Gross margin of 66.1% compared to 58.4% for the prior year quarter
• Net income of $1.3 million compared to a net loss of $5.0 million in the prior year quarter
• Adjusted EBITDA of $4.5 million compared to Adjusted EBITDA loss of $1.0 million in the prior year quarter
• Cash generated from operations of $4.6 million compared to cash used in operations of $1.7 million in the prior year quarter
• Reiterates FY25 revenue guidance to $131-$135 million, representing growth of 11%-15% over FY24 revenue

Read the full article on Seeking Alpha

For further details see: